MNPR

Monopar Therapeutics Inc.

NASDAQ

Add Alert

MNPR

Monopar Therapeutics Inc.

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

Dell_Griffith

09/13/24 8:15 AM

Post #70

Re: #69: @subslover - Hi Dell. That is some great DD you

You’re welcome. May take some time, but these are certainly not small-time players.

Regardless, if they’ve got a better way to treat people with illnesses, that’s a win-win.

subslover

09/12/24 6:43 PM

Post #69

Re: #68: @Dell_Griffith - Good info. Just checked this out today.

Hi Dell. That is some great DD you did and I thank you for letting me know. I have never even bought this stock, I just reported the news but now I will be looking for dips to possibly take at least a small starters position. Hope you are doing well and please stay in touch :)😍

Dell_Griffith

09/12/24 3:51 PM

Post #68

Re: #67: @subslover - Monopar Announces Positive Early Human Clinical Data Validating

Good info. Just checked this out today. Pretty damn impressive group of execs - CEO and COO went to Stanford. COO has a long history, including selling off companies he was CEO of to major players.

Bought a little high and was looking to flip, but I think I’m going to hold this one.

subslover

09/12/24 8:34 AM

Post #67

Re: #17: @Monksdream - MNPR new 52 week low https://investorshub.advfn.com/uimage/uploads/2023/9/1

Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
WILMETTE, Ill., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced positive early data from its ongoing open-label MNPR-101-Zr Phase 1 imaging and dosimetry clinical trial confirming MNPR-101-Zr’s tumor targeting ability in humans.

MNPR-101 is Monopar’s proprietary first-in-class humanized monoclonal antibody that targets cancers expressing the urokinase plasminogen activator receptor (uPAR). These include a majority of all triple-negative breast, colorectal, bladder, ovarian, gastric, and pancreatic cancers.

A total-body positron emission tomography (PET) image was taken at 168 hours (7 days) post administration of MNPR-101-Zr (a zirconium-89 imaging radioisotope conjugated to MNPR-101) of the first cancer patient in the trial with one of the known high uPAR-expressing cancer types. The results, seen in Figure 1, demonstrate the specificity, durability, and uptake of MNPR-101-Zr in the metastatic tumors relative to normal tissue. The regions of higher uptake also align with the locations of the previously observed metastatic tumors on conventional FDG PET imaging.

https://ml.globenewswire.com/Resource/Download/cda29080-7e74-46b0-8b93-5925a209f2ab/2024-9-11-pr-figure-1-jpeg.jpg

“This is exactly what we had hoped to see – highly preferential uptake in the tumor,” said Andrew Cittadine, Monopar’s Chief Operating Officer.

MNPR-101-Zr was evaluated against FDG, the gold standard for detecting metastatic tumors. Figure 2 shows FDG uptake in its highest-uptake tumor compared to MNPR-101-Zr uptake in the same tumor imaged on the same Siemens Biograph Vision Quadra™ PET/CT scanner.

https://ml.globenewswire.com/Resource/Download/cb0b4c63-91dc-46e1-a3c5-862ccc4251d8/2024-9-11-pr-figure-2-jpeg.jpg

“At the Melbourne Theranostic Innovation Centre, we utilize one of the world's most sensitive PET/CT scanners. Using the same scanner for FDG and MNPR-101-Zr, the results show MNPR-101-Zr achieved uptake at sites of known disease with retention out to late points, which is promising for future therapeutic translation,” said Professor Rodney Hicks, MBBS(Hons), MD, FRACP, FICIS, FAAHMS, lead investigator on the MNPR-101-Zr Phase 1 imaging and dosimetry clinical trial.

Monopar recently received clearance in Australia to initiate an MNPR-101-Lu Phase 1 therapeutic clinical trial [link] which is currently scheduled to launch in the fourth quarter of this calendar year.

“We are looking forward to sharing additional data at the upcoming European Association of Nuclear Medicine 2024 Annual Congress to be held in Hamburg, Germany on October 19-23, 2024, where our abstract has been accepted as a 'Top-Rated Oral Presentation' within the Scientific Program,” said Chandler Robinson, MD, Monopar’s Chief Executive Officer.

Further information about the ongoing MNPR-101-Zr Phase 1 imaging and dosimetry clinical trial is available at www.ClinicalTrials.gov under study identifier NCT06337084.

About Monopar Therapeutics Inc.

Monopar?Therapeutics is a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, including Phase 1-stage MNPR-101-Zr for imaging advanced cancers, Phase 1-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac225 for the treatment of advanced cancers, as well as early development stage programs against solid cancers. For more information, visit: www.monopartx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Examples of these forward-looking statements include: the results show MNPR-101-Zr achieved uptake at sites of known disease with retention out to late points, which is promising for future therapeutic translation; and that an MNPR-101-Lu Phase 1 therapeutic clinic

tw0122

09/12/24 8:20 AM

Post #66

$5.30 and 6.75 on high side and then $2.95- $4 is where most of the action will
Play out

Awl416

09/12/24 8:09 AM

Post #65

Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr

glenn1919

08/22/24 5:01 PM

Post #64

MNPR.............................https://stockcharts.com/h-sc/ui?s=MNPR&p=W&b=5&g=0&id=p86431144783

glenn1919

08/21/24 8:33 AM

Post #63

MNPR.........................................https://stockcharts.com/h-sc/ui?s=MNPR&p=W&b=5&g=0&id=p86431144783

Awl416

08/21/24 8:01 AM

Post #62

On August 21, 2024, Monopar Therapeutics Inc. (Monopar) issued a press release announcing that Monopar has received Human Research Ethics Committee (HREC) clearance in Australia to commence a Phase 1 therapeutic trial of its novel radiopharmaceutical MNPR-101-Lu.

PonkenPlonken

06/07/24 8:20 AM

Post #61

who killed the radiostar?
looking very great down here

Laster

06/06/24 10:23 AM

Post #60

Stock up 50% recently. Quietly moving higher.
They will report some data soon. Running in anticipation?
I like this stock a lot.
I think it has more to go.
JMO

TIMGZ

02/25/24 8:13 PM

Post #59

Re: #57: @Invest-in-America - MNPR: And let alone try to explain that

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173913331

glenn1919

02/24/24 8:38 AM

Post #58

MNPR................................................https://stockcharts.com/h-sc/ui?s=MNPR&p=W&b=5&g=0&id=p86431144783

Invest-in-America

02/23/24 4:28 PM

Post #57

Re: #56: @BurgerKing82 - If there really is 15 million shares OS...That

MNPR: And let alone try to explain that sudden (late-day) circa 240% soaring by @OCEA!!! And when one searches iHub's "ALL POSTS" about OCEA, one gets ambiguous posts about "Reddit was all over it", & "One guy threw $300,000 at it". BOY, that sure explains it all!!! (BONKERS STUFF, Bro!!)

BurgerKing82

02/23/24 4:19 PM

Post #56

Re: #52: @Invest-in-America - MNPR: So am I, Dude!! NOTHING anymore makes

If there really is 15 million shares OS...That could explain the run...Granted it is a Day 2 on a Friday,the Run fizzled

BurgerKing82

02/23/24 12:42 PM

Post #55

Re: #54: @TimeFades - Gamma squeeze

Wow it just crashed....idk what's next

TimeFades

02/23/24 12:16 PM

Post #54

Gamma squeeze

TimeFades

02/23/24 11:29 AM

Post #53

Still strong

Invest-in-America

02/23/24 10:22 AM

Post #52

Re: #51: @BurgerKing82 - Off to a bad Start...surprised there isn't any

MNPR: So am I, Dude!! NOTHING anymore makes any reasonable sense at all!!! (Their cheap FLUFF "news" of yesterday --- a mere Pre-Clinical Cancer stuff routine --- was patently UN-impressive at its core!! Yet today it soars!!)

BurgerKing82

02/23/24 4:30 AM

Post #51

Off to a bad Start...surprised there isn't any posters,on this board...Some wild moves in either direction

da_stock_analyst

02/22/24 8:19 PM

Post #50

#MNPR 🔥 gap fill to $2-$3 coming? Big upside! $MNPR

BurgerKing82

02/22/24 6:47 PM

Post #49

How many shares OS?

TimeFades

02/22/24 12:48 PM

Post #48

A lot of dumping

TimeFades

02/22/24 12:07 PM

Post #47

Spring tight ready for 1.5

TimeFades

02/22/24 11:10 AM

Post #46

Re: #44: @TheFinalCD - yep and still goin

Yup keeps popping off trend line

Invest-in-America

02/22/24 11:02 AM

Post #45

Re: #44: @TheFinalCD - yep and still goin

MNPR: You yourself have posted this sentiment countless times, Boss!!! NONE of this 'Wall Street' stuff makes ANY (rational) sense at all!!!

TheFinalCD

02/22/24 10:58 AM

Post #44

Re: #43: @Invest-in-America - MNPR: The obvious WINNER of this day!!! (And

yep and still goin

Invest-in-America

02/22/24 10:55 AM

Post #43

MNPR: The obvious WINNER of this day!!! (And all behind a mere PHASE-1 Cancer study routine!!! How the fluck can anyone call this stuff???!!!)

TimeFades

02/22/24 10:17 AM

Post #42

Level 2 just switched bullish

Awl416

02/22/24 7:07 AM

Post #41

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

Invest-in-America

02/20/24 11:18 AM

Post #40

Re: #39: @TheFinalCD - OH IVE BEEN BURNT BAD BEFORE

MNPR: WOW!! I hear-ya behind ALL of those notes, Boss!!! (And heck, I wouldn't mind being YOUR son --- his favorite 'WHEELS' is that red VET, no doubt??? Or, he's already FLIPPED a stock by himself, & bought his OWN Vet??? Naturally!!!)

TheFinalCD

02/20/24 11:09 AM

Post #39

Re: #31: @Invest-in-America - MNPR: Myself, I am NOT "embarrassed", because I

OH IVE BEEN BURNT BAD BEFORE

I WAS JUST TELLING MY 17YR OLD SON WHO I AM TEACHING HIM ABOUT THE MARKET

I TOLD HIM I LOST -$80K ON A PHASE 1 THAT GAPPED AND TRAPPED ME AND SO MANY OTHERS

THAT WAS BRUTAL

AND I DID IT A FEW TIMES AFTER, THEN GAVE UP ON PHASE 1 STOCKS

Fredric

02/20/24 10:38 AM

Post #38

Re: #37: @Invest-in-America - MNPR: Well then, CONGRATS to ya, Dude!!! (&

💪🏿

Invest-in-America

02/20/24 10:13 AM

Post #37

Re: #36: @Fredric - Yet n still I made money. You're expecting

MNPR: Well then, CONGRATS to ya, Dude!!! (& GOD BLESS!!!)

Fredric

02/20/24 10:10 AM

Post #36

Re: #35: @Invest-in-America - MNPR: There was NOTHING to be made in

Yet n still I made money. You're expecting to much.

Just take your profits n let it be. Arguing about it isn't gonna change that.the price is going back up
N my free shares looking good

Learn to have fun. Not cry. We know companies send out pr to stop the bleeding n gain investors attention

That's why we invest.we don't marry. Everyone wants money.

Take it accordingly

Good day sir. I'm off to the next investment

Invest-in-America

02/20/24 10:05 AM

Post #35

Re: #32: @Fredric - Smh 🤦🏿‍♂️ HOMEBOY You missed the point. K

MNPR: There was NOTHING to be made in the Pre-Market, either, Clown behind this scam!!! In case you didn't know that!!!

Fredric

02/20/24 10:02 AM

Post #34

Re: #33: @Fredric - Riding free shares

Took original plus extra holding a few for just in case.

That's how u trade

Fredric

02/20/24 10:01 AM

Post #33

Riding free shares

Fredric

02/20/24 10:00 AM

Post #32

Re: #30: @Invest-in-America - MNPR: And that "bet" is now OVER , Homeboy!!

Smh 🤦🏿‍♂️ HOMEBOY

You missed the point. Keep up.. Best bet is to trade with the big boys premarket in sell at open

Or buy after hours sell at premarket or open.

Flip in the case of last minute pr

Stop looking for a reason to argue

No one will listen to your rubbish

We don't need your explanation. Just say what you gotta say n leave it at that

Invest-in-America

02/20/24 9:59 AM

Post #31

Re: #22: @TheFinalCD - ITS FLYING BUT BE CAREFUL iVE LOST SO

MNPR: Myself, I am NOT "embarrassed", because I wasn't dumb enough to even THINK about buying this baloney sandwich (Pre-Colombian-Technology) "News". And certainly YOU --- Admiral TFCD --- weren't stupid enough either.

Bearish

Invest-in-America

02/20/24 9:54 AM

Post #30

Re: #29: @Fredric - Best bet

MNPR: And that "bet" is now OVER, Homeboy!! (Cheap --- merely Phase-1 "news" --- & still hyping old RADIATION gadgets!!! Stay AWAY from this kind of Pre-Colombian medical "technology"!!!)

Bearish

Fredric

02/20/24 9:48 AM

Post #29

Re: #28: @Invest-in-America - MNPR: This type of LAST MINUTE news is

Best bet

Invest-in-America

02/20/24 9:37 AM

Post #28

MNPR: This type of LAST MINUTE news is deliberately launched as such --- as if everyone doesn't yet know that. (HA-HAAAA!! Flip it really QUICK, if ya all grabbed some of this clever PR launch!!)

Fredric

02/20/24 9:34 AM

Post #27

Re: #26: @Fredric - I hate when halts. Its gonna one of

We will see

Fredric

02/20/24 9:34 AM

Post #26

Re: #25: @TheFinalCD - LETS SEE IF THIS HOLDS OR ANOTHER ALL

I hate when halts. Its gonna one of those days

Instituionals halting to take profit

It willhold for while think we see 1000% minimum

I was hoping for 50$ runner on strength n hype.but if they keep halting it we will see 10 -15$